Pluri (PLUR) FCF Margin Growth (1y) (2012 - 2025)
Pluri (PLUR) FCF Margin Growth (1y) (2012 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
FCF Margin Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
- |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
- |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
5,389.00 |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
- |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
- |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
1,525.00 |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
- |
| 10 |
Pluri |
21.39 Mn |
21.87 Mn |
86,000.00 |
-29,238.00 |
| Date | Value |
|---|
| Dec 31, 2025 |
-29,238.00 |
| Sep 30, 2025 |
-44,400.00 |
| Jun 30, 2025 |
301,142.00 |
| Mar 31, 2025 |
490,080.00 |
| Dec 31, 2024 |
102,831.00 |
| Sep 30, 2024 |
972,661.00 |
| Jun 30, 2024 |
-180,583.00 |
| Mar 31, 2024 |
96,209.00 |
| Dec 31, 2023 |
31.38 Mn |
| Sep 30, 2023 |
-220,715.00 |
| Mar 31, 2023 |
-296,344.00 |
| Dec 31, 2019 |
-1.05 Mn |
| Dec 31, 2018 |
-751,000.00 |
| Dec 31, 2015 |
547,465.00 |
| Sep 30, 2015 |
-21,684.00 |
| Dec 31, 2014 |
-291,474.00 |
| Sep 30, 2014 |
214,316.00 |
| Jun 30, 2014 |
-131,334.00 |
| Mar 31, 2014 |
-467,362.00 |
| Dec 31, 2013 |
-31,433.00 |
